RHYTHM PHARMACEUTICALS INC
RYTM·76243J105·US·Common Stock·Healthcare - Biotechnology-13D/G
RYTM (RHYTHM PHARMACEUTICALS INC) is held by 156 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($579.8M), BlackRock, Inc. ($542.4M), BAKER BROS. ADVISORS LP ($487.4M). Net institutional sentiment: Mixed.
156
Holders
(11 Elite)
$5.6B
Total Value
56% (160)
Consensus
90 buying - 70 selling
13F: Insider & Congress:
Who's Trading
ActivistPAPerceptive Advisors LLC5.1%May 15, 2026
InsiderGPGerman Christopher PaulSell $503KMar 4, 2026
InsiderSCSmith Hunter CSell $131KFeb 19, 2026
InsiderSCSmith Hunter CSell $171KFeb 19, 2026
InsiderSCSmith Hunter CSell $82KFeb 19, 2026
InsiderSCSmith Hunter CSell $60KFeb 19, 2026
InsiderSCSmith Hunter CSell $119KFeb 17, 2026
InsiderSCSmith Hunter CSell $20KFeb 17, 2026
Showing 1-20 of 169
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer